Company Description
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish se...
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Valuation
P/E Current
105.51
P/E Ratio (with extraordinary items)
53.47
P/E Ratio (without extraordinary items)
136.59
Price to Sales Ratio
3.14
Price to Book Ratio
1.82
Price to Cash Flow Ratio
25.48
Enterprise Value to EBITDA
20.09
Enterprise Value to Sales
3.31
Efficiency
Total Asset Turnover
0.44
Liquidity
Current Ratio
1.92
Quick Ratio
1.23
Cash Ratio
0.20
Profitability
Gross Margin
25.75
Operating Margin
7.65
Pretax Margin
3.04
Net Margin
2.30
Return on Assets
1.01
Return on Equity
1.96
Return on Total Capital
4.00
Capital Structure
Total Debt to Total Assets
30.76
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Mr. Franklin K. Clyburn | 56 | 2022 | Chief Executive Officer & Director |
Mr. Francisco Fortanet | 50 | 1995 | Executive Vice President-Operations |
Mr. Glenn Robert Richter | 59 | 2021 | Chief Financial Officer & Executive Vice President |
Mr. Vic Verma | 53 | 2016 | Chief Information Officer & Senior Vice President |
Dr. Gregory Yep | 54 | 2016 | Chief Global Scientific & Sustainability Officer |
Insider Actions
06/01/2022 |
Christophe de Villeplee President, Scent |
629 | Disposition at $132.59 per share. | 83,399 |
05/05/2022 |
Christina A. Gold Director |
1,089 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/05/2022 |
Ilene S. Gordon Director |
1,089 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/05/2022 |
Edward D. Breen Director |
1,089 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/05/2022 |
Kåre Schultz Director |
1,089 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/05/2022 |
Matthias J. Heinzel Director |
1,089 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/05/2022 |
Barry A. Bruno Director |
289 | Derivative/Non-derivative trans. at $0 per share. | 0 |
05/02/2022 |
Christophe de Villeplee President, Scent |
630 | Disposition at $121.68 per share. | 76,658 |
04/01/2022 |
Nicolas Mirzayantz President, Nourish |
2,042 | Derivative/Non-derivative trans. at $134.33 per share. | 274,301 |
04/01/2022 |
Francisco Fortanet EVP, Operations |
1,912 | Derivative/Non-derivative trans. at $134.33 per share. | 256,838 |
04/01/2022 |
Robert G. Anderson Controller |
625 | Derivative/Non-derivative trans. at $134.33 per share. | 83,956 |
04/01/2022 |
Christophe de Villeplee President, Scent |
256 | 34,388 | |
04/01/2022 |
Nicolas Mirzayantz President, Nourish |
4,353 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/01/2022 |
Francisco Fortanet EVP, Operations |
5,006 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/01/2022 |
Robert G. Anderson Controller |
1,741 | Derivative/Non-derivative trans. at $0 per share. | 0 |
04/01/2022 |
Christophe de Villeplee President, Scent |
285 | Derivative/Non-derivative trans. at $118.1 per share. | 33,658 |
04/01/2022 |
Christophe de Villeplee President, Scent |
2,176 | Derivative/Non-derivative trans. at $0 per share. | 0 |
03/15/2022 |
Robert G. Anderson Controller |
288 | Derivative/Non-derivative trans. at $120.48 per share. | 34,698 |
03/15/2022 |
Robert G. Anderson Controller |
662 | Award at $0 per share. | 0 |
02/19/2022 |
Simon W. Herriott President Health & Biosciences |
155 | Derivative/Non-derivative trans. at $135.03 per share. | 20,929 |
02/19/2022 |
Angela Strzelecki President, Pharma Solutions |
188 | Derivative/Non-derivative trans. at $135.03 per share. | 25,385 |
02/19/2022 |
Jennifer Johnson EVP, General Counsel |
273 | Derivative/Non-derivative trans. at $135.03 per share. | 36,863 |
02/19/2022 |
Simon W. Herriott President Health & Biosciences |
616 | Derivative/Non-derivative trans. at $0 per share. | 0 |
02/19/2022 |
Angela Strzelecki President, Pharma Solutions |
585 | Derivative/Non-derivative trans. at $0 per share. | 0 |
02/19/2022 |
Jennifer Johnson EVP, General Counsel |
708 | Derivative/Non-derivative trans. at $0 per share. | 0 |
02/14/2022 |
Simon W. Herriott President Health & Biosciences |
132 | Derivative/Non-derivative trans. at $132.1 per share. | 17,437 |
02/14/2022 |
Angela Strzelecki President, Pharma Solutions |
120 | Derivative/Non-derivative trans. at $132.1 per share. | 15,852 |
02/14/2022 |
Jennifer Johnson EVP, General Counsel |
152 | Derivative/Non-derivative trans. at $132.1 per share. | 20,079 |
02/14/2022 |
Simon W. Herriott President Health & Biosciences |
525 | Derivative/Non-derivative trans. at $0 per share. | 0 |
02/14/2022 |
Angela Strzelecki President, Pharma Solutions |
366 | Derivative/Non-derivative trans. at $0 per share. | 0 |
02/14/2022 |
Jennifer Johnson EVP, General Counsel |
366 | Derivative/Non-derivative trans. at $0 per share. | 0 |
01/02/2022 |
Christophe de Villeplee President, Scent |
784 | Derivative/Non-derivative trans. at $149.12 per share. | 116,910 |
12/31/2021 |
Simon W. Herriott President Health & Biosciences |
891 | Derivative/Non-derivative trans. at $149.82 per share. | 133,489 |
12/31/2021 |
Jennifer Johnson EVP, General Counsel |
1,236 | Derivative/Non-derivative trans. at $149.82 per share. | 185,177 |
12/31/2021 |
Simon W. Herriott President Health & Biosciences |
3,241 | Derivative/Non-derivative trans. at $0 per share. | 0 |
12/31/2021 |
Jennifer Johnson EVP, General Counsel |
3,241 | Derivative/Non-derivative trans. at $0 per share. | 0 |
12/30/2021 |
Angela Strzelecki President, Pharma Solutions |
3,481 | Derivative/Non-derivative trans. at $115.48 per share. | 401,985 |
MarketWatch News on IFF
-
International Flavors & Fragrances Inc. stock rises Friday, outperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock underperforms Thursday when compared to competitors
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Tuesday, underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock rises Tuesday, outperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock rises Monday, still underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Friday, still outperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock falls Tuesday, still outperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock rises Friday, still underperforms market
- MarketWatch Automation
-
International Flavors & Fragrances Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
- Loading more headlines...
Other News on IFF
-
DuPont, Eastman among five chemical companies cut at Jefferies
- Seeking Alpha
-
Tracking Carl Icahn's Portfolio - Q1 2022 Update
- Seeking Alpha
-
Summer Beauty Essentials: Your Guide To Hair Care, Makeup and Even Sunscreen
- Fiorella Valdesolo
-
Westlake downgraded at J.P. Morgan on recession risk, valuation
- Seeking Alpha
-
How Much the Biggest U.S. Companies Pay Workers
- John Stensholt
-
Wide-Moat Stocks On Sale - The June 2022 Heat Map
- Seeking Alpha
-
Gates Capital Management, Inc. Buys 2, Sells 3 in 1st Quarter
- GuruFocus.com
-
International Flavors & Fragrances Serves Up Value
- GuruFocus.com
-
Top 5 1st Quarter Trades of Sachem Head Capital Management LP
- GuruFocus.com
-
Wall Street Breakfast: What Moved Markets
- Seeking Alpha
-
Top 5 1st Quarter Trades of Searle & Co.
- GuruFocus.com
-
10-Q: INTERNATIONAL FLAVORS & FRAGRANCES INC
- Edgar Online - (EDG = 10Q, 10K)
-
International Flavors & Fragrances Q1 2022 Earnings Preview
- Seeking Alpha
- Loading more headlines...